U.S. Court of Appeals for the Federal Circuit, 2012

Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.

Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided December 27, 2012

Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.

Opinion

Case: 12-1498 Document: 47 Page: 1 Filed: 12/27/2012

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit __________________________ PRONOVA BIOPHARMA NORGE AS, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant, AND PAR PHARMACEUTICAL, INC. AND PAR PHARMACEUTICAL COMPANIES, INC., Defendants-Appellants. __________________________ 2012-1498, -1499 __________________________ Appeals from the United States District Court for the District of Delaware in consolidated case nos. 09-CV-0286 and 09-CV-0305, Judge Sue L. Robinson. __________________________ ON MOTION __________________________ ORDER Teva Pharmaceuticals USA, Inc. (“Teva”) and Par Pharmaceutical Companies, Inc. (collectively “Par”) Case: 12-1498 Document: 47 Page: 2 Filed: 12/27/2012

PRONOVA BIOPHARMA NORGE V. TEVA PHARMACEUTICALS 2

jointly move for an extension of time, until January 16, 2013 to file their reply briefs.

Upon consideration thereof, IT IS ORDERED THAT: (1) The December 19, 2012 motion is granted. (2) The December 13, 2012 motion is withdrawn.

FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s27

Case-law data current through December 31, 2025. Source: CourtListener bulk data.